Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
659
-
Total 13F shares, excl. options
-
24M
-
Shares change
-
-2.42M
-
Total reported value, excl. options
-
$12.3B
-
Value change
-
-$1.14B
-
Put/Call ratio
-
1.71
-
Number of buys
-
314
-
Number of sells
-
-328
-
Price
-
$514.16
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2025
737 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2025.
Medpace Holdings, Inc. - Common Stock (MEDP) has 659 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24M shares
of 28.4M outstanding shares and own 84.31% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.36M shares), VANGUARD GROUP INC (2.28M shares), AQR CAPITAL MANAGEMENT LLC (1.03M shares), WASATCH ADVISORS LP (926K shares), STATE STREET CORP (673K shares), Mawer Investment Management Ltd. (647K shares), GEODE CAPITAL MANAGEMENT, LLC (643K shares), D. E. Shaw & Co., Inc. (600K shares), BAILLIE GIFFORD & CO (585K shares), and Invesco Ltd. (537K shares).
This table shows the top 659 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.